CRS

DEVICE3 trials

Sponsors

University of Regensburg, Zhongnan Hospital, -

Conditions

Chronic Rhinosinusitis chronic rhinosinusitis eosinophilic rhinosinusitis Nasal Polyps endoscopic sinus surgery recurrent sinusitis uncontrolled sinusitisColorectal Cancer MetastaticEpithelial Ovarian CancerHyperthermic Intraperitoneal Chemotherapy(HIPEC)Ovarian CancerOvarian Cancer, EpithelialOvarian NeoplasmsOvary Neoplasm

Phase 2

Combined Anticancer Treatment of Advanced Colon Cancer

TerminatedNCT01540344

University of RegensburgColorectal Cancer Metastatic, Peritoneal Carcinomatosis

Start: 2010-10-31End: 2017-10-31Updated: 2018-09-05

Phase 3

Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced and Recurrent Epithelial Ovarian Cancer

Zhongnan HospitalEpithelial Ovarian Cancer, Hyperthermic Intraperitoneal Chemotherapy(HIPEC), Ovarian Cancer +3

Start: 2017-09-30End: 2023-03-30Updated: 2020-05-29

Unknown Phase

The association between tissue eosinophilia and the time to disease recurrence of chronic rhinosinusitis after endoscopic sinus surgery

RecruitingTCTR20150719001

-Chronic Rhinosinusitis chronic rhinosinusitis eosinophilic rhinosinusitis Nasal Polyps endoscopic sinus surgery recurrent sinusitis uncontrolled sinusitis

Start: 2015-07-10Target: 100Updated: 2026-08-03

Related Papers

Multimodality treatment of colorectal peritoneal metastasis with perioperative systemic chemotherapy, cytoreductive surgery (CRS), and HIPEC: First safety results of the COMBATAC trial.

Journal of Clinical Oncology2014-01-202 citations

A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial.

2013-02-0731 citations